MiMedx Group, Inc.
MiMedx Group, Inc. (MDXG) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mdxg · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$10.00
Consensus
$10.00
+168.5% upside
Low
$10.00
Median: $10 · Last Close: $3.73
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.76 | ↑ 0.96% |
1-day model range: $3.74–$3.78. Peak: $3.78 (+0.96%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -35.7% |
| 2028 | $2 | -48.3% |
| 2029 | $2 | -53.8% |
| 2030 | $2 | -56.6% |
| 2031 | — | -58.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MDXG · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-30 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-20 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-17 | Craig-Hallum | Maintains | Buy→Buy |
| 2026-02-17 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-01-20 | Lake Street | Maintains | Buy→Buy |
| 2025-12-17 | Mizuho | Maintains | Outperform→Outperform |
| 2025-07-31 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-07-15 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-02-27 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-08-01 | Craig-Hallum | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on MiMedx Group, Inc. (MDXG) stock. Of the recent 44 rating actions, 6 were upgrades and 5 were downgrades. 15 analysts currently cover MDXG.
Analyst Recommendation Trends
MDXG analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$269M
↓ 21.2% YoY
Revenue Next Year
$302M
↑ 12.4% YoY
EPS This Year
$-0.06
EPS Next Year
$0.08
↓ 237.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast MDXG EPS of $-0.06 for the current fiscal year, based on estimates from 3 analysts. The MDXG revenue forecast is $269M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MDXG stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MDXG price target is $10.00 (+168.5% upside), with an analyst consensus of Buy.
The MDXG short-term stock prediction for tomorrow is $3.76 (+0.96%). The MDXG stock price prediction for 2027 estimates an average of $2. The MDXG stock prediction for 2030 projects a range of $2–$2.
MiMedx Group, Inc. trades on NASDAQ under the ticker MDXG. The MDXG stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
MDXG forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month MDXG price target is $10.00, with a high forecast of $10.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +168.5% potential upside from the current price of $3.73.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.